Change in number of shares and votes in EQL Pharma AB
During September 2025, the number of shares and votes in EQL Pharma AB ("EQL Pharma") has increased as a result of the exercise of warrants issued pursuant to two warrant programs adopted by the annual general meeting on 17 August 2021 and the extraordinary general meeting on 10 December 2021, respectively.
As of 30 September 2025, the total number of shares and votes in EQL Pharma amounts to 29,529,610.
This disclosure contains information that EQL Pharma is obliged to make public pursuant to the Swedish Financial Instruments Trading Act. The information was submitted for publication, through the agency of the contact person, on "Innehållet inom klamrarna kommer ersättas med rätt tid och datum vid utskickstillfället">30-09-2025 10:00 CET.
For more information contact:
Axel Schörling,
CEO & President EQL Pharma AB (publ)
Phone: +46 (0) 76 317 90 60
E-mail: axel.schorling@eqlpharma.com
Web: www.eqlpharma.com
Bifogade filer